Nuance Investments LLC Buys 2,708,097 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Nuance Investments LLC increased its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 25.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 13,545,981 shares of the medical instruments supplier’s stock after purchasing an additional 2,708,097 shares during the quarter. DENTSPLY SIRONA accounts for approximately 10.4% of Nuance Investments LLC’s holdings, making the stock its biggest position. Nuance Investments LLC owned approximately 0.07% of DENTSPLY SIRONA worth $257,103,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in XRAY. Natixis Advisors LLC boosted its stake in shares of DENTSPLY SIRONA by 21.1% during the 3rd quarter. Natixis Advisors LLC now owns 21,733 shares of the medical instruments supplier’s stock worth $588,000 after acquiring an additional 3,787 shares in the last quarter. Charles Schwab Investment Management Inc. raised its holdings in DENTSPLY SIRONA by 50.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 2,065,773 shares of the medical instruments supplier’s stock worth $55,900,000 after purchasing an additional 692,100 shares during the last quarter. Raymond James Trust N.A. boosted its position in DENTSPLY SIRONA by 37.7% during the third quarter. Raymond James Trust N.A. now owns 13,299 shares of the medical instruments supplier’s stock worth $360,000 after purchasing an additional 3,641 shares in the last quarter. Cerity Partners LLC acquired a new stake in DENTSPLY SIRONA in the third quarter valued at $482,000. Finally, QVIDTVM Management LLC increased its position in shares of DENTSPLY SIRONA by 75.8% in the third quarter. QVIDTVM Management LLC now owns 458,866 shares of the medical instruments supplier’s stock valued at $12,417,000 after buying an additional 197,803 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

Insider Buying and Selling

In other DENTSPLY SIRONA news, Director Gregory T. Lucier acquired 15,142 shares of the firm’s stock in a transaction on Monday, March 3rd. The stock was bought at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the purchase, the director now directly owns 81,971 shares in the company, valued at $1,353,341.21. This represents a 22.66 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 0.52% of the company’s stock.

Analyst Ratings Changes

XRAY has been the topic of a number of research reports. Wells Fargo & Company lowered their price objective on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating on the stock in a research note on Friday, February 28th. Robert W. Baird dropped their price objective on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a research note on Friday, February 28th. Evercore ISI reaffirmed an “in-line” rating and issued a $20.00 target price on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Barrington Research dropped their price target on DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating for the company in a research report on Friday, February 28th. Finally, Mizuho cut their price target on DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating for the company in a report on Thursday, March 13th. Twelve investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $23.33.

DENTSPLY SIRONA Trading Down 1.5 %

Shares of XRAY opened at $15.57 on Wednesday. DENTSPLY SIRONA Inc. has a twelve month low of $14.78 and a twelve month high of $33.42. The firm has a market capitalization of $3.10 billion, a P/E ratio of -7.52, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The stock’s fifty day simple moving average is $17.86 and its 200 day simple moving average is $20.40.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.11%. The ex-dividend date of this dividend is Friday, March 28th. DENTSPLY SIRONA’s payout ratio is currently -14.07%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.